translation agency

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update
GEORGIA: AIDS Vaccine 200 Bicycle Ride Will Benefit AIDS Vaccine Research
Holly Korschun
March 29, 2013
Emory News Center (Atlanta) (03.27.13)

This year’s AIDS Vaccine 200 (AV200), an annual 200-mile bicycle ride event that benefits AIDS vaccine research at the Emory Vaccine Center in Atlanta, Ga., projects that more than 200 riders will participate on May 18–19.The volunteer-run Action Cycling Atlanta is sponsoring the event, which will begin at Emory University in Atlanta and travel to Eatonton, Ga., located in the Oconee National Forest, and back to Emory. Since its beginning 11 years ago, AV200 has raised more than $1 million for AIDS vaccine research. The Emory Vaccine Center is the largest and most comprehensive academic vaccine center in the world. Some of the projects supported by Action Cycling’s annual AV200 include the development of one of the world’s first preventative HIV/AIDS vaccines, currently in phase II clinical trial testing, and work at the vaccine center’s satellite campus in New Delhi, India, on development of an HIV/AIDS vaccine designed specifically for the clade-C strain of HIV that is prevalent in that country. For further information about the AV200 bicycle ride, visit For more information about the Emory Vaccine Center, visit